PMC14 PERSONAL DRUG UTILIZATION REPORT (PDUR)—A CONTRIBUTION TO COST REDUCTION AND PATIENT EMPOWERMENT  by Lentges, N et al.
773Abstracts
PMC14
PERSONAL DRUG UTILIZATION REPORT (PDUR)—A
CONTRIBUTION TO COST REDUCTION AND PATIENT
EMPOWERMENT
Lentges N,Verheyen F, Hecke TL, Müller H
Techniker Krankenkasse, Hamburg, Germany
OBJECTIVES: The lack of transparency in health care is one of
the major obstacles to ensure rational and cost-effective use of
health care resources. Reduction of costs for drugs is an impor-
tant challenge for the statutory sickness funds in Germany. The
Techniker Krankenkasse (TK) as one of the largest statutory sick-
ness funds pays special attention to this development by offer-
ing an individualized service to their insurees called “Personal
Drug Utilization Report” (PDUR). This service informs patients
about their drug use behaviours and is expected to discuss either
with the physician or the pharmacist. PDUR aims to: 1) Improve
patients’ knowledge about their drug utilization; 2) inﬂuence
their behaviours; 3)contribute to patients’ active participation in
the medical decision process; and 4)strenghthen patients’ com-
pliance. METHODS: Based on pharmacy claims data, the
patients receive their PDUR upon request that comprises all
drugs and medical devices prescribed by a physician and dis-
pensed by community pharmacies. Currently, PDUR covers the
prescription data of the last 24 months and lists following items:
product name, dispensing date, dispensing pharmacies, co-
payments, central pharmaceutical number. RESULTS: PDUR has
found a wide acceptance with the TK insurees: from August,
2003 to May, 2004 50,000 (17.9% of all eligible patients for
this service) asked for their individual PDUR. CONCLUSIONS:
Expanding health-orientated services, elaborating drug informa-
tion systems and strengthening the patient role in the health care
system are of importance for TK. The high grade of acceptance
shows that PDUR ﬁts the patientsx need and expectancies.
PDUR is considered as a ﬁrst module to implement other tools
like an electronic patient dossier and will be supplemented by
other health-related services. In the future, all PDUR will be
accompanied by a satisfaction survey. First results of a health-
economic evaluation are expected for the end of this year.
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WEIGHING DIAGNOSES IN EVALUATION STUDIES WITH AN
APPLICATION TO SYNCOPE
Boer KR,Van Dijk N,Wieling W, Dijkgraaf MGW
Academic Medical Center / University of Amsterdam, Amsterdam,
Netherlands
OBJECTIVES: It is difﬁcult to assess the efﬁciency of diagnostic
strategies without knowledge of the outcome of subsequent
treatment. This is particularly true for strategies that aim to iden-
tify various diagnoses, each of which leading to a different treat-
ment. We propose a methodology for weighing different
diagnoses, illustrated by a diagnostic study of syncope.
METHODS: After listing all diagnoses (n = 27) that might
explain the occurrences of syncope, we ﬁrst applied the reper-
tory grid technique of Kelly’s personal construct theory to a core
group of internists, a neurologist and a cardiologist to produce
assessment criteria that are relevant for the weighing of diag-
noses. Secondly, we invited an extended expert panel of 11 spe-
cialists to score the relevance of each criterion on a 0–10 visual
analogue scale and, subsequently, to rank each diagnosis at each
criterion on a 0–100 scale. The third step consists of calculating
the summed products of the criterion relevance scores and the
diagnosis rank scores at each criterion for each diagnosis sepa-
rately to derive diagnosis speciﬁc weights. RESULTS: The core
specialist group identiﬁed eight criteria for the weighing of
syncope diagnoses. The criteria were, by descending order of rel-
evance: mortality (7.4), treatability (6.6), quality of life (5.8),
prognosis (5.4), frequency of episodes (5.1), presence of presyn-
cope (4.2), treatment costs (3.3), and prevalence (3.0). The most
important diagnoses were secondary (2432) and primary (2407)
autonomic failure syndromes, acute aortic dissection (2266), and
obstructive cardiomyopathy (2156). The least important ones
were hyperventilation with hypocapnia (1296) and volume
depletion (1152). CONCLUSIONS: The presented methodology
succesfully generated diagnosis speciﬁc weights that can be used
for the evaluation of diagnostic strategies during decision mod-
eling. The methodology will further be strenghtened by an expert
panel consensus meeting between the second and third steps to
clarify and minimize score and ranking differences.
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VISUAL ANALOGUE SCALES: ARE THE ELICITED
PREFERENCES ANALOGUE?
Akunne AF, Bridges JFP, Sauerborn R
University of Heidelberg, Heidelberg, Baden-Wuerrtembe, Germany
OBJECTIVES: This study compared the reliability and feasibil-
ity of three different versions of VAS on socioeconomic hetero-
geneous groups in a developing country. METHODS: Ten health
states were described and applied on forty adults with mean age
33. In the ﬁrst version, 10 cubes were placed against health
states, and respondents were requested to remove the number of
cubes equivalent to loss in health associated with the state with
ten cubes equivalent to full health and zero cube equivalent to
death. In the second version, they had the conventional VAS and
were requested to point at the scale. Thirdly, respondents were
requested to pick from a collection of cubes the number equiv-
alent to each health state with ten cubes equal to death and no
cube being equivalent to full health. Mean explanation and 
valuation times were 5 and 18 minutes respectively. Thirteen
percent of the respondents had problems understanding the ﬁrst
version of the instrument. RESULTS: The standard deviation of
the elicited values with the second version was highest for all the
disease cases (Disease: Std{1st, 2nd, 3rd version}; Epilepsy:
Std{0.25, 0.28, 0.23}, Bronchitis: Std{0.20, 0.27, 0.22}, Dental
Pain: Std{0.21, 0.23, 0.18}, Vertigo: Std{0.17, 0.23, 0.17},
Madness: Std{0.29, 0.32, 0.28}, etc). ANOVA procedure showed
that mean scores obtained using the different versions were sta-
tistically different for eight out of the ten diseases (Epilepsy
{<.0003}, Bronchitis {<0.0012}, Dental Pain {<0.0165}, Vertigo
{<0.0001}, Madness {<0.8321}, etc). CONCLUSIONS: In 
comparing the preferences elicited with VAS, caution should 
be exercised as different modiﬁcations of the instrument 
were demonstrated to yield different values. In the elicitation
process, the alternative versions of VAS may have allowed the
incorporation of other values which lacked with the conven-
tional VAS.
PMC17
THERE’S NO F IN UTILITY
Kind P
Outcomes Research Group,York, UK
OBJECTIVES: It is generally held that quality-adjustment
weights used to compute QALYs must be elicited using utilities.
This paper challenges that orthodoxy in three ways.
METHODS: Firstly, the legitimacy of cardinal utility measure-
ment itself is questioned. The absence of a single standard
method for eliciting utilities and the divergence of results
obtained by variants of techniques such as Standard Gamble and
Time Trade-Off provides evidence of the non-unique status of
utility measurement. The failure to identify an ex post test of the
status of utility measurement means that it is impossible even to
